Abstract

Vol. 120, No. 12 News | Science SelectionsOpen AccessCrispy Cravings May Affect Baby’s Health: Prenatal Acrylamide Exposure Is Associated with Reduced Birth Weight Julia R. Barrett Julia R. Barrett Search for more papers by this author Published:1 December 2012https://doi.org/10.1289/ehp.120-a475bCited by:1View Article in:中文版AboutSectionsPDF ToolsDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InReddit Many commonly eaten foods contain acrylamide, a known neurotoxicant and suspected human carcinogen. Previous animal studies have suggested acrylamide may also cause reduced birth weight in prenatally exposed offspring. Investigators now report an association between higher concentrations of acrylamide and glycidamide hemoglobin adducts in umbilical cord blood and reduced birth weight in children of women who ate diets rich in acrylamide [EHP 120(12):1739–1745; Pedersen et al.].Acrylamide forms during frying or high-temperature baking of carbohydrate-rich foods such as fried potatoes, potato chips, cookies, and breakfast cereals. Within the body, acrylamide and its metabolite glycidamide form adducts, or chemically joined products, with proteins and DNA. These adducts can potentially disrupt genetic and biological functions.Pregnant women at 11 locations in Denmark, Greece, Norway, Spain, and England participated in the study during 2006–2011, and the investigators used information on 1,101 mother–child pairs. Demographic and detailed dietary information was collected from all the women, umbilical cord blood samples were obtained at birth, and birth information was extracted from medical records.Acrylamide and glycidamide hemoglobin adducts were found in all cord blood samples, and levels tended to be higher if the mother smoked. Subsequent analyses accounted for maternal smoking as well as other potentially confounding factors, such as length of pregnancy, child’s sex and country of birth, and mother’s age, prepregnancy weight, and ethnicity.New findings suggest that eating a diet rich in acrylamide during pregnancy could increase the risk of low birth weight.© 2012 Rob Mattingley/iStockphoto.comThe investigators found an association between decreasing birth weight and increasing levels of adducts. In a comparison of the highest and lowest quartiles of exposure among children of nonsmoking mothers, acrylamide and glycidamide were associated with average birth weight decreases of 107 and 103 g (3.8 and 3.6 oz), respectively. These decreases are comparable with those attributed to moderate smoking during pregnancy. Reduced birth weight is linked with adverse health effects such as impaired growth and development early in life and increased incidence of cardiovascular disease, diabetes, and osteoporosis in adulthood.The availability of adduct measurements and the large, well-characterized study population are key strengths of the study. However, there remained the potential for unmeasured or uncontrolled factors to influence the results. Furthermore, it was not possible to precisely characterize dietary acrylamide intake, because even in the same types of foods, levels can vary depending on manufacturing and preparation methods. If confirmed by further research, the results of this study suggest that pregnant women may benefit from reduced consumption of acrylamide-containing foods.FiguresReferencesRelatedDetailsCited by Krishna G, Divyashri G, Prapulla S and Muralidhara (2015) A Combination Supplement of Fructo- and Xylo-Oligosaccharides Significantly Abrogates Oxidative Impairments and Neurotoxicity in Maternal/Fetal Milieu Following Gestational Exposure to Acrylamide in Rat, Neurochemical Research, 10.1007/s11064-015-1687-x, 40:9, (1904-1918), Online publication date: 1-Sep-2015. Vol. 120, No. 12 December 2012Metrics About Article Metrics Publication History Originally published3 December 2012Published in print1 December 2012 Financial disclosuresPDF download License information EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. Note to readers with disabilities EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact [email protected]. Our staff will work with you to assess and meet your accessibility needs within 3 working days.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.